Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Publication year range
1.
Clin Transl Oncol ; 22(12): 2333-2340, 2020 Dec.
Article in English | MEDLINE | ID: mdl-32449125

ABSTRACT

PURPOSE: Locally advanced non-small cell lung cancer (LA-NSCLC) is frequently treated with chemoradiotherapy (CRT). Despite the efforts, long-term outcomes are poor, and novel therapies have been introduced to improve results. Biomarkers are needed to detect early treatment failure and plan future follow-up and therapies. Our aim is to evaluate the role of dynamics of neutrophil-to-lymphocyte ratio (NLR) in patients with locally advanced NSCLC treated with CRT. METHODS: We retrospectively reviewed patients diagnosed with LA-NSCLC receiving definitive CRT at our center from 2010 to 2015. Baseline and post-treatment NLR were collected from our center database. NLR was dichotomized (threshold = 4) and patients were divided into two groups based on the variation from baseline to post-treatment NLR. The prognostic role and association with response were examined with logistic regression and multivariate Cox regression model, respectively. RESULTS: Ninety-two patients were included. Our analysis shows that NLR after treatment is associated with response to treatment [OR in the multivariate analysis 4.94 (1.01-24.48); p value = 0.048]. Furthermore, NLR and ECOG are independent prognostic factors for progression-free survival (PFS) and overall survival (OS). Specifically, PFS was 25.79 months for the good prognosis group and 12.09 for the poor prognosis group [HR 2.98 (CI 95% = 1.74-5.10), p < 0.001]; and OS was 42.94 months and 18.86 months, respectively [HR 2.81 (CI 95% = 1.62-4.90), p < 0.001]. CONCLUSION: Dynamics of NLR have a prognostic value in stage III NSCLC treated with definitive CRT. Pre- and post-CRT NLR should be evaluated in prospective clinical trials involving consolidation treatment with immunotherapy.


Subject(s)
Carcinoma, Non-Small-Cell Lung/blood , Lung Neoplasms/blood , Lymphocytes/cytology , Neutrophils/cytology , Adult , Aged , Aged, 80 and over , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Carcinoma, Non-Small-Cell Lung/mortality , Carcinoma, Non-Small-Cell Lung/pathology , Carcinoma, Non-Small-Cell Lung/therapy , Chemoradiotherapy , Female , Humans , Leukocyte Count , Logistic Models , Lung Neoplasms/mortality , Lung Neoplasms/pathology , Lung Neoplasms/therapy , Lymphocyte Count , Male , Middle Aged , Prognosis , Progression-Free Survival , Proportional Hazards Models , Retrospective Studies , Treatment Outcome
2.
Zh Nevrol Psikhiatr Im S S Korsakova ; 120(3. Vyp. 2): 33-41, 2020.
Article in Russian | MEDLINE | ID: mdl-32307428

ABSTRACT

INTRODUCTION: This paper is an adapted translation of recommendations on telestroke provided by the European Stroke Organization. Lack of stroke specialists determines that many European rural areas remain underserved. Use of telemedicine in stroke care has shown to be safe, increase use of evidence-based therapy and enable coverage of large areas of low population density. An aim of the study is to summarise the following recommendations of the Telestroke Committee of the European Stroke Organization on the setup of telestroke networks in Europe: Hospitals participating in telestroke networks should be chosen according to criteria that include population density, transportation distance, geographic specifics and in-hospital infrastructure and professional resources. Three hospital categories are identified to be part of a hub-and-spoke network: (1) the Telemedicine Stroke Centre (an European Stroke Organization stroke centre or equivalent with specific infrastructure and setup for network and telemedicine support), (2) the telemedicine-assisted stroke Unit (equivalent to an European Stroke Organization stroke unit but without 24 h onsite stroke expertise) and (3) the telemedicine-assisted stroke ready hospital (only covering hyperacute treatment in the emergency department and transferring all patients for further treatment).


Subject(s)
Stroke/therapy , Telemedicine/organization & administration , Europe , Humans , Practice Guidelines as Topic , Telemedicine/standards , Translations
3.
Rev Bras Pesqui Med Biol ; 8(5-6): 481-7, 1975.
Article in English | MEDLINE | ID: mdl-1219939

ABSTRACT

The DC otential between the jejunal mucosa and the skin of the tail's root was measured in 29 rats. In twenty animals the superior mesenteric artery was clamped during up to VBJ minutes and recording of the DC potential was performed before vascular obstruction, during the period of ischaemia, and after revascularization was resumed when the clamp was removed. Prolonged ischaemia of the jejunum led to increasing reduction of the DC potential but recovery occurred about 75% of the rats when revascularization was established. The remaining 25% did not recover from vascular occlusion due to thrombosis or mechanical damage to the arterial wall. After removal of the elctrodes from the former group functional recovery of the intestinal function occurred in all the animals in which the removal was successful and no perforation of the intestinal wall was produced. Measuring transmural potential may be a convenient method to assess the viability of an infarcted intestine, thus aiding in selecting the appropriate therapeutic measures and in prognostic evaluation.


Subject(s)
Ligation , Skin Physiological Phenomena , Surgical Procedures, Operative , Tail/physiology , Animals , Ischemia , Male , Potentiometry , Rats
SELECTION OF CITATIONS
SEARCH DETAIL
...